1. Чучалин АГ, Визель АА, Илькович ММ, и др. Диагностика и лечение саркоидоза. Резюме федеральных согласительных клинических рекомендаций. Часть I. Классификация, этиопатогенез, клиника. Вестник современной клинической медицины. 2014;7(4):62-70. doi:10.20969/VSKM.2014.7(4).1-82.
2. Swigris JJ, Olson AL, Huie TJ, et al. Sarcoidosis-related mortality in the United States from 1988 to 2007. Am J Respir Crit Care Med. 2011;183:1524-30. doi:10.1164/rccm.201010-1679OC.
3. Birnie DH, Sauer WH, Bogun F, et al. HRS Expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11:1305-23. doi:10.1016/j.hrthm.2014.03.043.
4. Kandolin R, Lehtonen J, Kupari M. Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults. Circ Arrhythm Electrophysiol. 2011;4:303-9. doi:10.1161/CIRCEP.110.959254.
5. Nery PB, Beanlands RS, Nair G, et al. Middle aged patients with new onset atrioventricular block should be investigated for cardiac sarcoidosis. Heart Rhythm. 2013;10:S447. doi:10.1111/jce.12401.
6. Greulich S, Deluigi CC, Gloekler S, et al. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. JACC Cardiovasc Imaging. 2013;6:501-11. doi:10.1016/j.jcmg.2012.10.021.
7. Slart R, Glaudemans A, Lancelotti P, et al. A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology. Euro Heart J Cardiovasc Imaging. 2017;18:1073-89. doi:10.1093/ehjci/jex146.
8. Sadek MM, Yung D, Birnie DH, et al. Corticosteroid therapy for cardiac sarcoidosis: systematic review. Can J Cardiol. 2013;29:1034-41. doi:10.1016/j.cjca.2013.02.004.
9. Miyazaki S, Funabashi N, Nagai T, et al. Cardiac sarcoidosis complicated with atrioventricular block and wall thinning, edema and fibrosis in left ventricle: confirmed recovery to normal sinus rhythm and visualization of edema improvement by administration of predonisolone. Int J Cardiol. 2011;150:e4-e10. doi:10.1016/j.ijcard.2009.05.047.
10. Yodogawa K, Seino Y, Shiomura R, et al. Recovery of atrioventricular block following steroid therapy in patients with cardiac sarcoidosis. J Cardiol. 2013;62:320-5. doi:10.1016/j.jjcc.2013.07.007.
11. Yodogawa K, Seino Y, Ohara T, et al. Effect of corticosteroid therapy on ventricular arrhythmias in patients with cardiac sarcoidosis. Ann Noninvasive Electrocardiol. 2011;16:140-7. doi:10.5582/irdr.2015.01023.
12. Houston BA, Mukherjee M. Cardiac sarcoidosis: clinical manifestations, imaging characteristics, and therapeutic approach. Clinical Medicine Insights. Cardiology. 2014;8(Suppl 1):31-7. doi:10.4137/CMC.S15713.
13. Lynch JP, Hwang J, Bradfield J, et al. Cardiac involvement in sarcoidosis: evolving concepts in diagnosis and treatment. Semin Respir Crit Care Med. 2014;35(3):372-90. doi:10.1055/s-0034-1376889.
14. Моисеева О. М., Михайлов Е. Н., Митрофанова Л. Б., и др. Изолированный саркоидоз сердца: разбор клинического случая и обзор литературы. Российский кардиологический журнал. 2016;(1):99-104. doi:10.15829/1560-4071-2016-1-99-104.
15. Kim JS, Judson MA, Donnino R, et al. Cardiac sarcoidosis. Am Heart J. 2009;157(1):9-21. doi:10.1016/j.ahj.2008.09.009.